Fibronectin promotes proplatelet formation in the human megakaryocytic cell line UT‐7/TPO
Tatsuya Kawaguchi(Kumamoto Health Science University), Hiroshi Yokota(Daiichi-Sankyo (Japan)), Ryo Hatano(Juntendo University), Ryuji Hashimoto(Daiichi-Sankyo (Japan)), Kyoji Yamaguchi(Daiichi-Sankyo (Japan)), Katsuhiko Nawa(Daiichi-Sankyo (Japan))
Cited by 13
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
|Biochemical and Biophysical Research Communications|1998|746
Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures
|Biochemical and Biophysical Research Communications|1998|344